Models for Predicting Response to Immunotherapy and Prognosis in Patients with Gastric Cancer: DNA Damage Response Genes

Figure 9

A comprehensive analysis of the response of two groups of gastric cancer patients receiving immunotherapy. (a, b) Association of DDR-related genetic risk scores with MSI. (c) Differences in TIDE scores between the two groups. (d, e) Association of DDR-related genetic risk scores with TMB. (f, g) Waterfall plot of the top 20 genes in somatic mutation frequency in both groups. (h, i) Kaplan-Meier analysis of combined TMB and risk scores in patients with gastric cancer. (j) The relationship between the two risk groups of gastric cancer patients and immune checkpoint. (k) The relationship between the two risk groups of patients and drug sensitivity.

(a)

(b)

(c)

(d)

(e)

(f)

(g)

(h)

(i)

(j)

(k)